MILESTONE - Reports First Quarter Results and Provides Business Update (14/2014) /EBI

MILESTONE - Milestone Medical Inc. Reports First Quarter Results and Provides Business Update (14/2014) /EBI

15.05.2014 | aktual.: 19.05.2014 16:17

| | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | NEW CONNECT | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | Raport EBI nr | 14 | / | 2014 | | | | |
| | | | | | | | | | | | |
| | Data sporządzenia: | 2014-05-15 | | | | | | | | | |
| | | | | | | | | | | | |
| | Skrócona nazwa emitenta | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | Temat | | | | | | | | | | |
| | Milestone Medical Inc. Reports First Quarter Results and Provides Business Update | | | | | | | | | | |
| | Podstawa prawna | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | Treść raportu: | | | | | | | | | | |
| | LIVINGSTON, NJ, May 15, 2014 - Milestone Medical Inc. (WAR: MMD), today announced financial results for the quarter ended March 31, 2014 and provided a general business update. Leonard Osser, Chief Executive Officer of Milestone Medical stated, “We have made significant progress thus far as we await regulatory approval for our epidural and intra-articular instruments. We continue to focus our efforts on setting up strategic partnerships with distributors worldwide to ensure a seamless rollout of the two instruments upon regulatory approval. As announced last year, we already have a distribution channel in place with one of largest specialty distributors of healthcare products in the United States to market and sell our epidural instrument. We look forward to creating similar agreements in other markets this year.\" Mr. Osser continued, “As announced earlier this month, our Board of Directors has approved plans for Milestone Medical to uplist from the NewConnect Market to the Main Market of the Warsaw
Stock Exchange, which we expect to occur in the second half of this year, subject to approval of the Company\'s prospectus. Transitioning to the Main Market of the Warsaw Stock Exchange will be an important development for us as we believe this will help increase awareness and expand the number of potential investors in our company. In tandem with the uplisting, we expect to complete a public offering of our shares, which we expect will occur at a substantial premium to our prior offering. Notwithstanding, we have successfully kept our cash burn to just $75,000 per month, while aggressively pursuing regulatory approval and new distribution partners for our instruments. With over $1.6 million of cash and over $3.4 million of shareholders\' equity at the end of the first quarter, we have more than sufficient capital to carry us through regulatory approval.\" Conference Call Milestone Medical\'s executive management team will host a conference call at 2:30 p.m. Central European Time (8:30 a.m. Eastern Time), on
Friday, May 16, 2014 The conference call can be accessed via a live Internet webcast on the Company\'s website at www.medicalmilestone.com. A webcast replay of the conference call will be accessible on the Company\'s website at www.medicalmilestone.com for 90 days. Legal basis: Section 3.1 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market\" | | | | | | | | | | |
| | | | | | | | | | | | |
| | Załączniki | | | | | | | | | | |
| | Plik | Opis | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |

RAPORT BIEŻĄCY
MESSAGE (ENGLISH VERSION)
INFORMACJE O PODMIOCIE
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ

MESSAGE (ENGLISH VERSION)

RAPORT BIEŻĄCY
MESSAGE (ENGLISH VERSION)
INFORMACJE O PODMIOCIE
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ

| | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | (telefon) | (fax) | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | (NIP)
| (REGON) | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | (pełna nazwa emitenta) | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | (ulica) | (numer) | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | (e-mail) | (www) | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | (kod pocztowy)
| (miejscowość) | | | | | | | | |
| | | | | | | | | | | | | | |

RAPORT BIEŻĄCY
MESSAGE (ENGLISH VERSION)
INFORMACJE O PODMIOCIE
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ

PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
Imię i Nazwisko Stanowisko/Funkcja Podpis Data
Leonard Osser CEO
Joseph D\'Agostino CFO

RAPORT BIEŻĄCY
MESSAGE (ENGLISH VERSION)
INFORMACJE O PODMIOCIE
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ

Wybrane dla Ciebie
Komentarze (0)